Study title: A phase III, randomised, controlled, multicenter study in adults, investigating the antibody response to postexposure rabies vaccination combined with Human Rabies Immune Globuline (HRIG) between two types of tissue culture rabies vaccines, Purified vero cell rabies vaccine (PVRV) and Purified chick embryo cell rabies vaccine (PCECV)
Type of medicine: Non-centrally authorised vaccines | |||||
Therapeutic area: Virus Diseases | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: RABIES VACCINE FOR HUMAN USE PREPARED FROM CELL CULTURE (DIPLOID CELLS) | |||||
ATC code: J07BG01 | |||||
Document link: | |||||
Document date: 2014-10-09 | |||||
Study number: BI 1.061 / 7T--304RA | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |